Patrick Trucchio
Stock Analyst at HC Wainwright & Co.
(4.00)
# 483
Out of 5,182 analysts
352
Total ratings
42.66%
Success rate
13.71%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASMB Assembly Biosciences | Assumes: Buy | $50 | $29.85 | +67.50% | 1 | Aug 18, 2025 | |
| ALT Altimmune | Reiterates: Buy | $12 | $3.38 | +255.03% | 19 | Aug 13, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $500 → $570 | $321.28 | +77.42% | 27 | Aug 7, 2025 | |
| CMPS COMPASS Pathways | Maintains: Buy | $45 → $40 | $5.58 | +616.85% | 17 | Aug 4, 2025 | |
| ATAI AtaiBeckley | Maintains: Buy | $10 → $15 | $3.70 | +305.41% | 20 | Jul 30, 2025 | |
| ANRO Alto Neuroscience | Reiterates: Buy | $10 | $22.40 | -55.36% | 2 | Jun 26, 2025 | |
| IVVD Invivyd | Reiterates: Buy | $5 | $1.78 | +180.90% | 19 | Jun 26, 2025 | |
| SGMO Sangamo Therapeutics | Reiterates: Buy | $10 | $0.26 | +3,718.25% | 26 | Jun 24, 2025 | |
| SLN Silence Therapeutics | Reiterates: Buy | $75 | $5.80 | +1,193.10% | 24 | Jun 13, 2025 | |
| IMCR Immunocore Holdings | Reiterates: Buy | $100 | $31.81 | +214.37% | 21 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $16.30 | +329.45% | 15 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.04 | +380.77% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $6.61 | +807.72% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $66.23 | +20.79% | 23 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $15.27 | +161.95% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $3.96 | +657.58% | 10 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $29.16 | +140.05% | 6 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $26.33 | +203.84% | 8 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $10 | $2.01 | +397.51% | 19 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.37 | +2,591.07% | 16 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $9.83 | +1,019.02% | 23 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $85.91 | -1.06% | 2 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $68 | $11.02 | +517.06% | 2 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $260 → $340 | $62.39 | +444.96% | 1 | Aug 18, 2021 |
Assembly Biosciences
Aug 18, 2025
Assumes: Buy
Price Target: $50
Current: $29.85
Upside: +67.50%
Altimmune
Aug 13, 2025
Reiterates: Buy
Price Target: $12
Current: $3.38
Upside: +255.03%
Alnylam Pharmaceuticals
Aug 7, 2025
Maintains: Buy
Price Target: $500 → $570
Current: $321.28
Upside: +77.42%
COMPASS Pathways
Aug 4, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $5.58
Upside: +616.85%
AtaiBeckley
Jul 30, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $3.70
Upside: +305.41%
Alto Neuroscience
Jun 26, 2025
Reiterates: Buy
Price Target: $10
Current: $22.40
Upside: -55.36%
Invivyd
Jun 26, 2025
Reiterates: Buy
Price Target: $5
Current: $1.78
Upside: +180.90%
Sangamo Therapeutics
Jun 24, 2025
Reiterates: Buy
Price Target: $10
Current: $0.26
Upside: +3,718.25%
Silence Therapeutics
Jun 13, 2025
Reiterates: Buy
Price Target: $75
Current: $5.80
Upside: +1,193.10%
Immunocore Holdings
Jun 2, 2025
Reiterates: Buy
Price Target: $100
Current: $31.81
Upside: +214.37%
May 29, 2025
Reiterates: Buy
Price Target: $70
Current: $16.30
Upside: +329.45%
May 21, 2025
Reiterates: Buy
Price Target: $5
Current: $1.04
Upside: +380.77%
May 21, 2025
Reiterates: Buy
Price Target: $60
Current: $6.61
Upside: +807.72%
May 20, 2025
Reiterates: Buy
Price Target: $80
Current: $66.23
Upside: +20.79%
May 9, 2025
Reiterates: Buy
Price Target: $40
Current: $15.27
Upside: +161.95%
Apr 8, 2025
Reiterates: Buy
Price Target: $30
Current: $3.96
Upside: +657.58%
Apr 8, 2025
Reiterates: Buy
Price Target: $70
Current: $29.16
Upside: +140.05%
Apr 7, 2025
Reiterates: Buy
Price Target: $80
Current: $26.33
Upside: +203.84%
Apr 1, 2025
Maintains: Buy
Price Target: $25 → $10
Current: $2.01
Upside: +397.51%
Mar 18, 2025
Reiterates: Buy
Price Target: $10
Current: $0.37
Upside: +2,591.07%
Feb 28, 2025
Reiterates: Buy
Price Target: $110
Current: $9.83
Upside: +1,019.02%
Feb 19, 2025
Reiterates: Buy
Price Target: $85
Current: $85.91
Upside: -1.06%
Sep 23, 2022
Maintains: Buy
Price Target: $170 → $68
Current: $11.02
Upside: +517.06%
Aug 18, 2021
Maintains: Outperform
Price Target: $260 → $340
Current: $62.39
Upside: +444.96%